Intravenous dexmedetomidine inhibits cerebrovascular dilation induced by isoflurane and sevoflurane in dogs

Anesthesia and Analgesia

Volumn 89, Issue 2, 1999, Pages 370-377

  Ohata, Hiroto ^a   Iida, Hiroki ^a   Dohi, Shuji ^a   Watanabe, Yukinaga ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; INHALATION ANESTHETIC AGENT; ISOFLURANE; PENTOBARBITAL; SEVOFLURANE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DOG; DOSE RESPONSE; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; VASODILATATION; VENULE;

EID: 0032803196     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199908000-00023     Document Type: Article

References (27)

1. Tsukahara T, Taniguchi T, Usui H, et al. Sympathetic denervation and alpha adrenoceptors in dog cerebral arteries. Naunyn Schmiedebergs Arch Pharmacol 1986;334:436-43.
2. Ishiyama T, Dohi S, Iida H, et al. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg 1995;81:1208-15.
3. Asano Y, Koehler RC, Kawaguchi T, McPherson R. Pial arteriolar constriction to alpha-2 adrenergic agonist dexmedetomidine in the rat. Am J Physiol 1997;272:H2547-56.
4. Ganjoo P, Farber NE, Hudetz A, et al. In vivo effects of dexmedetomidine on laser-Doppler flow and pial arteriolar diameter. Anesthesiology 1998;88:429-39.
5. Crawford MW, Lerman J, Saldivia V, et al. Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia during spontaneous ventilation. Anesth Analg 1992;75: 1000-6.
6. Conzen PF, Vollmar B, Habazettl H, et al. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992;74:79-88.
7. Scheller MS, Tateishi A, Drummond JC, et al. The effects of sevoflurane on cerebral blood flow, cerebral metabolic rate for oxygen, intracranial pressure, and the electroencephalogram are similar to those of isoflurane in the rabbit. Anesthesiology 1988; 68:548-51.
8. Young WL, Prohovnik I, Correll JW, et al. A comparison of the cerebral hemodynamics effects of sufentanil and isoflurane in humans undergoing carotid endarterectomy. Anesthesiology 1989;71:863-9.
9. Kitaguchi K, Ohsumi H, Kuro M, et al. Effects of sevoflurane on cerebral circulation and metabolism in patients with ischemic cerebrovascular disease. Anesthesiology 1993;79:704-9.
10. Ferrari-DiLeo G, Potter LT. Alpha-adrenoceptors and muscarine receptors in human pial arteries and microvessels: a receptor binding study. J Cereb Blood Flow Metab 1985;5:458-64.
11. Harik SI, Sharma VK, Wetherbee JR, et al. Adrenergic and cholinergic receptors of cerebral microvessels. J Cereb Blood Flow Metab 1981;1:329-38.
12. Bujija DW, Leffler CW. Postjunctional alpha-2 adrenoceptors in pial arteries of anesthetized newborn pigs. Dev Pharmacol Ther 1987;10:36-46.
13. Auer LM, Johansson BB, Lund S. Reaction of pial arteries and veins to sympathetic stimulation in the cat. Stroke 1981;12: 528-31.
14. Kazama T, Ikeda K. Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiology 1988;68:435-7.
15. 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 1990;70:624-30.
16. Sprague DH, Yang JC, Ngai SH. Effects of isoflurane and halothane on contractility and the cyclic 3′, 5′-adenosine monophosphate system in the rat aorta. Anesthesiology 1974;40:162-7.
17. Boyer JL, Cardenas C, Posadas C, et al. Pertussis toxin induces tachycardia and impairs the increase in blood pressure produced by alpha2-adrenergic agonists. Life Sci 1983;33:2627-33.
18. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
19. + channel activation. Anesthesiology 1998;89:954-60.
20. Raffa RB, Martinez RP. The 'glibenclamide-shift' of centrally-acting antinociceptive agents in mice. Brain Res 1995;677: 277-82.
21. Aantaa R, Kanto J, Scheinin M, et al. Dexmedetomidine, an alpha-2 adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 1990;73:230-5.
22. Aho M, Lehtinen AM, Erkola O, et al. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology 1991;74:997-1002.
23. Aantaa R, Jaakala ML, Kallio A, et al. A comparison of dexmedetomidine, an alpha2-adrenoceptor agonist, and midazolam as i.m. premedication for minor gynaecological surgery. Br J Anaesth 1991;67:402-9.
24. 2 agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 1990;71:125-9.
25. Coughlan MG, Lee JG, Bosnjak ZJ, et al. Direct coronary and cerebral vascular responses to dexmedetomidine. Anesthesiology 1992;77:998-1006.
26. McPherson RW, Koehler RC, Kirsch JR, et al. Intraventricular dexmedetomidine decreases cerebral blood flow during normoxia and hypoxia in dogs. Anesth Analg 1997;84:139-47.
27. Hatano Y, Nakamura K, Moriyama S, et al. The contractile responses of isolated dog cerebral and extracerebral arteries to oxybarbiturates and thiobarbiturates. Anesthesiology 1989;71: 80-6.